A Single Blind Phase IV Pharmacodynamic Study to Evaluate Neutrophil Distribution Kinetics and Function Following Single-Dose Tocilizumab Treatment in Healthy Subjects

Trial Profile

A Single Blind Phase IV Pharmacodynamic Study to Evaluate Neutrophil Distribution Kinetics and Function Following Single-Dose Tocilizumab Treatment in Healthy Subjects

Completed
Phase of Trial: Phase IV

Latest Information Update: 19 Nov 2015

At a glance

  • Drugs Tocilizumab (Primary)
  • Indications Ankylosing spondylitis; Chronic lymphocytic leukaemia; Crohn's disease; Dermatomyositis; Giant cell arteritis; Giant lymph node hyperplasia; Juvenile rheumatoid arthritis; Multiple myeloma; Pancreatic cancer; Polymyositis; Rheumatoid arthritis; Systemic lupus erythematosus; Systemic scleroderma; Vasculitis
  • Focus Pharmacodynamics
  • Sponsors Roche
  • Most Recent Events

    • 26 Jan 2015 Status changed from recruiting to completed, as reported by ClinicalTrials.gov.
    • 12 Jan 2015 Status changed from active, no longer recruiting to recruiting as reported by ClinicalTrials.gov.
    • 23 Dec 2014 Status changed from recruiting to active, no longer recruiting as reported by ClinicalTrials.gov record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top